Cargando…
How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application
Complement, as a central immune surveillance system, can be activated within seconds upon stimulation, thereby displaying multiple immune effector functions. However, in pathologic scenarios (like in tumor progression), activated complement can both display protective effects to control tumor develo...
Autores principales: | Luo, Shanshan, Wang, Moran, Wang, Huafang, Hu, Desheng, Zipfel, Peter F., Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658260/ https://www.ncbi.nlm.nih.gov/pubmed/33193442 http://dx.doi.org/10.3389/fimmu.2020.593610 |
Ejemplares similares
-
Complement in Hemolysis- and Thrombosis- Related Diseases
por: Luo, Shanshan, et al.
Publicado: (2020) -
Double-edged functions of hemopexin in hematological related diseases: from basic mechanisms to clinical application
por: Li, Yijin, et al.
Publicado: (2023) -
Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
por: Chretien, Anne-Sophie, et al.
Publicado: (2022) -
Influence of graft composition in patients with hematological malignancies undergoing ATG-based haploidentical stem cell transplantation
por: Zhang, Ran, et al.
Publicado: (2022) -
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
por: Zhang, Xiaomin, et al.
Publicado: (2022)